Literature DB >> 15832056

Intraluminal application of vascular endothelial growth factor enhances healing of microvascular anastomosis in a rat model.

Manfred Infanger1, Mehdi Shakibaei, Peter Kossmehl, Siri M Hollenberg, Jirka Grosse, Shideh Faramarzi, Gundula Schulze-Tanzil, Martin Paul, Daniela Grimm.   

Abstract

BACKGROUND: Early reconstitution after injury to the endothelium is an important feature for reducing a number of vessel wall pathologies. We investigated the effect of vascular endothelial growth factor (VEGF) and its impact on the vascular remodeling process and reendothelialization after microsurgery. METHODS AND
RESULTS: Microvascular anastomosis was performed in the rat femoral artery. One group was treated with intraluminal administration of VEGF and the other with vehicle. We investigated morphological, ultrastructural and immunohistochemical changes of the vascular wall and the reendothelialization process. After 10 days, reendothelialization was significantly faster in VEGF-treated rats. Transmission electron microscopy revealed a complete healing in contrast to vehicle-treated vessels. Moreover, extracellular matrix proteins, such as fibronectin, collagen types I, III and IV, were significantly increased. Furthermore, VEGF treatment significantly induced VEGF receptor 2, flk-1, osteopontin and TGF-beta(1) proteins.
CONCLUSIONS: Our data clearly document for the first time that intraluminal treatment with VEGF is beneficial to the healing process in vascular microsurgery. Osteopontin and TGF-beta(1), both induced by VEGF, may play an important role in the vascular remodeling process. Our results provide clear evidence that VEGF application may represent a useful strategy in accelerating reendothelialization and improving vascular healing after microsurgery. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832056     DOI: 10.1159/000085176

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  7 in total

Review 1.  Biomarkers for anti-angiogenic therapy in cancer.

Authors:  Markus Wehland; Johann Bauer; Nils E Magnusson; Manfred Infanger; Daniela Grimm
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

Review 2.  Anti-vascular endothelial growth factor therapy in breast cancer.

Authors:  Tina Bøgelund Kristensen; Malin L T Knutsson; Markus Wehland; Britt Elmedal Laursen; Daniela Grimm; Elisabeth Warnke; Nils E Magnusson
Journal:  Int J Mol Sci       Date:  2014-12-11       Impact factor: 5.923

3.  Preparation of A Spaceflight: Apoptosis Search in Sutured Wound Healing Models.

Authors:  Stefan Riwaldt; Monica Monici; Asbjørn Graver Petersen; Uffe Birk Jensen; Katja Evert; Desiré Pantalone; Kirsten Utpatel; Matthias Evert; Markus Wehland; Marcus Krüger; Sascha Kopp; Sofie Frandsen; Thomas Corydon; Jayashree Sahana; Johann Bauer; Ronald Lützenberg; Manfred Infanger; Daniela Grimm
Journal:  Int J Mol Sci       Date:  2017-12-03       Impact factor: 5.923

Review 4.  The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors.

Authors:  Ole Vincent Ancker; Markus Wehland; Johann Bauer; Manfred Infanger; Daniela Grimm
Journal:  Int J Mol Sci       Date:  2017-03-14       Impact factor: 5.923

Review 5.  Role of Apoptosis in Wound Healing and Apoptosis Alterations in Microgravity.

Authors:  Stefan Riwaldt; Thomas J Corydon; Desiré Pantalone; Jayashree Sahana; Petra Wise; Markus Wehland; Marcus Krüger; Daniela Melnik; Sascha Kopp; Manfred Infanger; Daniela Grimm
Journal:  Front Bioeng Biotechnol       Date:  2021-06-17

6.  Mechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity.

Authors:  Sascha Kopp; Elisabeth Warnke; Markus Wehland; Ganna Aleshcheva; Nils E Magnusson; Ruth Hemmersbach; Thomas Juhl Corydon; Johann Bauer; Manfred Infanger; Daniela Grimm
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

7.  Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone Marrow.

Authors:  Simone Pacini; Serena Barachini; Marina Montali; Vittoria Carnicelli; Rita Fazzi; Paolo Parchi; Mario Petrini
Journal:  Stem Cells Dev       Date:  2016-04-11       Impact factor: 3.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.